CLDI Calidi Biotherapeutics, Inc. Stock — fundamentals, financials & AI research · AlgoThesis

Stocks›Healthcare›CLDI

CLDI

Name: AlgoThesis
Author: algothesis

Calidi Biotherapeutics, Inc.

NYSEResearch view

Healthcare · Biological Products, (No Diagnostic Substances) · SEC EDGAR FY 2022-12-31

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2022-12-31

SectorHealthcare

Income$-25.4M

Sales$45,000

Book/sh$-19.52

Cash/sh$0.23

Dividend TTM—

Payout—

Employees—

IPO—

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

Revenue history unavailable.

Financials — annual

SEC EDGAR · last 1 FY · tap a row to explain it

USD	FY2022
Revenue	$45,000
Gross Profit	—
Operating Income	$-23.1M
Net Income	$-25.4M
Diluted EPS	$2.99
Operating Cash Flow	$-13.2M
Free Cash Flow	—

COMMUNITY · $CLDI0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Build basket with CLDI Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.